Rubric Capital Management (New York)’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$158K Sell
2025
Q1
$1.66M Hold
2024
Q4
$4.96M Hold
2024
Q3
$6.27M Hold
2024
Q2
$4.09M Hold
2024
Q1
$16.2M Hold
2023
Q4
$17.1M Sell
2023
Q3
$20.9M Hold
2023
Q2
$17.9M Sell
2023
Q1
$18.1M Buy
2022
Q4
$12.7M Buy
2022
Q3
$8.31M Buy
2022
Q2
$6.2M Buy